Accuray Inc (ARAY) stock
ARAYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
$2.80−0.28 (-9.09%)
Close on Nov 13, 2026Market cap $334.43MP/E –Yield –
Accuray total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Accuray's total debt was $101.67M at Sep 30, 2026. For fiscal 2026 it was $147.87M, down 0.9% from the year before. Over ten years it grew -3.5% a year on average. The highest annual figure on record is $210.41M in fiscal 2016.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $147.87M | -0.9% |
| FY2025 | Jun 30, 2025 | $149.25M | -17.0% |
| FY2024 | Jun 30, 2024 | $179.91M | -1.7% |
| FY2023 | Jun 30, 2023 | $183.00M | -3.2% |
| FY2022 | Jun 30, 2022 | $189.03M | +6.4% |
| FY2021 | Jun 30, 2021 | $177.59M | -6.2% |
| FY2020 | Jun 30, 2020 | $189.31M | +18.4% |
| FY2019 | Jun 30, 2019 | $159.84M | +21.9% |
| FY2018 | Jun 30, 2018 | $131.08M | -20.4% |
| FY2017 | Jun 30, 2017 | $164.57M | -21.8% |
| FY2016 | Jun 30, 2016 | $210.41M | +5.4% |
| FY2015 | Jun 30, 2015 | $199.66M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $101.67M | -33.6% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $147.87M | -0.9% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $145.18M | -19.9% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $135.89M | -25.8% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $153.02M | -14.0% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $149.25M | -17.0% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $181.36M | +0.3% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $183.07M | +0.9% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $178.01M | -2.3% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $179.91M | -1.7% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $180.74M | -1.9% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $181.50M | -2.2% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $182.25M | +0.1% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $183.00M | -3.2% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $184.26M | -2.7% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $185.51M | -2.1% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $182.03M | -9.7% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $189.03M | +6.4% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $189.30M | -6.3% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $189.57M | -1.8% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $201.47M | +8.4% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $177.59M | -6.2% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $201.97M | +5.9% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $193.14M | +5.0% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $185.85M | -1.4% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $189.31M | +18.4% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $190.66M | +30.6% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $183.86M | +34.4% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $188.46M | +46.2% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $159.84M | +21.9% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $145.96M | +8.7% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $136.82M | -13.4% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $128.93M | -21.7% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $131.08M | -22.9% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $134.32M | -21.1% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $158.02M | -9.7% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $164.57M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $170.04M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $170.17M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $175.02M | – |
See a number that looks wrong?